Glial cell response: A pathogenic factor in Parkinson's disease

Author： Wu Du Chu Tieu Kim Cohen Oren Choi Dong-Kug Vila Miquel Jackson-Lewis Vernice Teismann Peter Przedborski Serge

ISSN： 1355-0284

Source： Journal of NeuroVirology, Vol.8, Iss.6, 2002-12, pp. : 551-558

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astrocyte Delivery of Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease

By Cunningham L.A. Su C.

Experimental Neurology, Vol. 174, Iss. 2, 2002-04 ,pp. : 230-242

Elsevier

Access to resources Recommend Favorite

Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

By Lapchak P.A. Gash D.M. Collins F. Hilt D. Miller P.J. Araujo D.M.

Experimental Neurology, Vol. 145, Iss. 2, 1997-06 ,pp. : 309-321

Elsevier

Access to resources Recommend Favorite

Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease

By Lapchak P.A. Gash D.M. Jiao S. Miller P.J. Hilt D.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 29-34

Elsevier

Access to resources Recommend Favorite

Mutation Analysis of the Glial Cell Line-Derived Neurotrophic Factor Gene in Parkinson's Disease

By Wartiovaara K. Hytonen M. Vuori M. Paulin L. Rinne J. Sariola H.

Experimental Neurology, Vol. 152, Iss. 2, 1998-08 ,pp. : 307-309

Elsevier

Access to resources Recommend Favorite

Recombinant Adeno-associated Viral Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Protects Nigral Dopamine Neurons after Onset of Progressive Degeneration in a Rat Model of Parkinson's Disease

By Mandel R.J. Snyder R.O. Leff S.E.

Experimental Neurology, Vol. 160, Iss. 1, 1999-11 ,pp. : 205-214

Elsevier

Access to resources Recommend Favorite